Short answer: Direct compression — blending powders and pressing directly, with no intermediate step — is the right default for small labs and startups. It needs no granulation equipment, no drying step, and no cleanroom-grade process control, and a pre-balanced direct-compression excipient system can compensate for a wide range of active ingredients. Wet granulation is still worth the extra equipment and time for actives with genuinely poor flow or compressibility that direct compression can't correct, or for very high-dose actives where excipient headroom runs out.
Most first-time formulators have heard of wet granulation because it's the traditional pharmaceutical-scale method, and assume it's the "correct" or more serious approach. For a small lab running trial and early commercial batches, that assumption usually adds cost and complexity without a corresponding benefit.
What Each Method Actually Involves
Direct compression blends the active ingredient with excipients — a binder, filler, glidant, and lubricant — and presses the blend straight into tablets. The entire process is mixing and compression: no intermediate steps, no drying, no additional equipment beyond a mixer and a press.
Wet granulation adds a liquid binder to the powder blend to form larger, denser granules, then dries and mills those granules before compression. It solves flow and compressibility problems by physically restructuring the powder — but it requires granulation equipment, a drying step (oven or fluid-bed dryer), and tighter process control to get consistent granule size run to run.
Why Direct Compression Is the Practical Default for Small Labs
Lower equipment cost. Direct compression needs a mixer and a press — the same equipment checklist as any first production run. Wet granulation adds a granulator and a dryer, both real capital costs and both additional things that can go wrong.
Faster batch turnaround. No drying step means a direct-compression batch can go from raw powder to finished tablet in one continuous run. Wet granulation's drying step alone can add hours per batch — a meaningful difference when you're iterating on a formulation and running multiple trial batches in a week.
Fewer process variables to control. Granulation introduces liquid-to-powder ratio, drying time, drying temperature, and mill screen size as additional variables that all affect the final tablet. Direct compression has fewer knobs, which makes it easier to isolate what's actually causing a problem when a batch doesn't come out right.
A pre-balanced powder removes the hardest part. The traditional argument for granulation is that many actives don't flow or compress well on their own. A direct-compression excipient system formulated to correct for that — like ReadyBlend, which mixes at 20–60% with an active ingredient — closes most of that gap without adding a granulation step.
When Wet Granulation Is Still Worth It
Direct compression isn't universal, and forcing it on the wrong active wastes more time than granulating would have. Reach for wet granulation when:
- The active has genuinely poor flow or compressibility that excipients alone can't correct — very fine, cohesive, or low-density powders that bridge or segregate no matter how they're blended.
- The active is a very high dose relative to tablet size, leaving little room for the excipients that make direct compression work. Granulation lets the active itself become part of the granule structure instead of competing with excipients for space.
- You need to blend multiple actives with very different particle sizes or densities, where segregation during compression is a real risk — granulation locks the blend together before it ever reaches the die.
If tablets are coming out soft, capping, or laminating and you've already ruled out a flow problem, that's the point to evaluate whether granulation — not just a different direct-compression excipient — is the actual fix. See diagnosing capping and lamination for how to tell the two apart.